SMALES KELLY sold 5.2% of their position (4K shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $19.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/1/2024ACC: 0001415889-24-006071
-4K
Net shares
Net seller
$19.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$4.81
Trade value
$19.22K
% of position
5.2%
2/28/2024
77.55K→73.56K
Total
Net shares
−4K
Net value
-$19.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2024 | S · Sale | −4K | $4.81 | $19.22K | 5.2% | 77.55K | 73.56K |
| Total | −4K | -$19.22K | ||||||
Derivative Transactions0
No derivative transactions reported